Medtronic received information that prior to the implant of a transcatheter bioprosthetic valve, an edwards sapien valve was attempted to be implanted but was unable to access the vessel.The transcatheter bioprosthetic valve was attempted and still was unable to access the vessel.A dissection of the left femoral artery was reported and required vascular surgery to repair the vessel.It is unknown when the vessel dissected.It was reported that the delivery catheter system (dcs) did not make it to the level of the dissection, however the edwards valve did.No further adverse patient effects were reported.(b)(4).This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
|